Recent studies have demonstrated that this variation in ANGPTL8 in metabolic syndrome is associated with a lower risk of hypercholesterolemia, hyperglycemia, insulin resistance, etc. [11]. This evidence concerns the gene ANGPTL8 and Hypercholesterolemia.